Home
 

Companies News


Avalon to Receive Funding from Ontario Government for Separation Rapids Lithium Project.

Avalon Advanced Materials {TSX: AVL} is pleased to announce that the Government of Ontario has agreed to contribute $500,000 towards assisting Avalon with piloting and scaling up its proprietary process developed to recover high purity lithium hydroxide from the lithium mineral petalite produced from the 100% owned Separation Rapids Lithium Project, Kenora, ON. Continue reading

Crypto currencies taking a breather after their strong run – Ethereum incident

Bitcoin {BTC} and fellow crtypto currencies have reversed somewhat after their recent strong run, which has seen some coins run up to ridiculous multiples of where they were a few short weeks ago.

Ethereum is the best example of that, and recently suffered a catastrophic collapse, only to recover minutes later, wiping out some investors in the process. Continue reading

Neometals has lodged three US patent applications for spent lithium battery recycling

Neometals Ltd {ASX: NMT}  announced that it has lodged three US provisional patent applications associated with its technology to recover high‐value materials from spent lithium batteries. The scoping studies completed to date confirm that the technology can economically recover high‐value cobalt (99.2% recovery), at potentially lowest quartile operating cost. Continue reading

Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International Convention.

Inovio Pharmaceuticals, Inc. {NASDAQ: INO}  announced that Dr. J. Joseph Kim, President & CEO, will participate on a panel, titled “Platform Technologies: The Key to Responding to Emerging Infectious Diseases,” at the 2017 BIO International Conference at the San Diego Convention Center on Wednesday, June 21, 2017. Continue reading

Neometals featured in Daily Mail article – Share buyback update

Neomatals {ASX: NMT} The recent presentation by MD Chris Reed in London has been featured in a Daily Mail article, focusing on the potential to separate the company into two and for the technical side to be listed in the USA, where markets are more receptive to tech stories.

The company continued the share buyback program of 28 million shares, passing the halfway mark. Continue reading

Inovio Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial

Inovio Pharmaceuticals, Inc. {NASDAQ: INO} today announced that it has completed enrollment of its phase 1 clinical trial in Puerto Rico evaluating its Zika vaccine, GLS-5700.

This second phase 1 study (ZIKA-002) was designed to assess safety, tolerability, and immune responses in the setting of potentially ongoing disease transmission. Continue reading